Back to Search
Start Over
New guidelines for the prevention of imported malaria in France
- Source :
- Médecine et Maladies Infectieuses, Médecine et Maladies Infectieuses, Elsevier Masson, 2019, ⟨10.1016/j.medmal.2019.07.004⟩, Médecine et Maladies Infectieuses, 2019, ⟨10.1016/j.medmal.2019.07.004⟩
- Publication Year :
- 2018
-
Abstract
- Prevention of malaria is based on personal vector-control measures (PVCMs) to avoid mosquito bites at night and chemoprophylaxis if justified by the risk of contracting the disease. The most effective PVCM is the use of insecticide-treated mosquito nets. The decision to prescribe chemoprophylaxis, mainly to prevent Plasmodium falciparum infection, depends on the benefit-risk ratio. Overall, the risk of contracting malaria is 1,000-fold lower during a stay in the tropical regions of Asia or the Americas than in sub-Saharan Africa. For "conventional" stays (less than one month with nights spent in urban areas) in low-risk settings in tropical Asia and America, the risk of being infected with Plasmodium parasites (≤1/100,000) is equivalent or lower than that of experiencing serious adverse effects caused by chemoprophylaxis. Preventive medication is therefore no longer recommended. By contrast, in other settings and particularly in sub-Saharan Africa, chemoprophylaxis is the most effective measure against malaria. However, it is worth noting that no single preventive measure provides full protection. Regardless of the level of risk or chemoprophylaxis-related indication, protection against mosquito bites and rapid management of febrile illness after returning from an endemic area are also critical to prevent malaria. Finally, migrants of sub-Saharan origin visiting friends and relatives in their country of origin form a high-risk group who should be recommended chemoprophylaxis in the same way as any other travelers-with a preference for the least expensive molecules (doxycycline).
- Subjects :
- Visiting friends and relatives
Disease
Chemoprevention
03 medical and health sciences
[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system
[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases
Communicable Diseases, Imported
Environmental health
parasitic diseases
medicine
Humans
[SDV.MP.PAR]Life Sciences [q-bio]/Microbiology and Parasitology/Parasitology
Adverse effect
ComputingMilieux_MISCELLANEOUS
Imported malaria
[SDV.MHEP.ME]Life Sciences [q-bio]/Human health and pathology/Emerging diseases
0303 health sciences
030306 microbiology
business.industry
Endemic area
medicine.disease
[SDV.MP.BAC]Life Sciences [q-bio]/Microbiology and Parasitology/Bacteriology
Country of origin
3. Good health
Malaria
Infectious Diseases
[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/Virology
Chemoprophylaxis
Practice Guidelines as Topic
France
business
Subjects
Details
- ISSN :
- 17696690 and 0399077X
- Volume :
- 50
- Issue :
- 2
- Database :
- OpenAIRE
- Journal :
- Medecine et maladies infectieuses
- Accession number :
- edsair.doi.dedup.....7339f5bf3bd8f7b3582bb1f8522391ea
- Full Text :
- https://doi.org/10.1016/j.medmal.2019.07.004⟩